Flagystatin · DIN 01926829 · 500 mg & 100000U · Vag suppository
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Flagystatin · DIN 01926829
Manufacturer: Sanofi Aventis Pharma; listing date 1996-10-01
Health Canada: Marketed since 2007-12-11 · brand FLAGYSTATIN · ATC G01AA51 NYSTATIN, COMBINATIONS · form Ovule · route Vaginal · ingredients METRONIDAZOLE 500 MG, NYSTATIN 100000 UNIT · company Sanofi-aventis canada inc · schedule Prescription
Flagystatin: Formulary list price $3.85 per unit (the source does not state the unit; exact figure $3.8510). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01926829)
Source record
DIN 01926829: Flagystatin
Raw flags: sec3=Y
Item: 840416020; group id 831; item number 2024; lccId None; manufacturer id SAV
Source form: Vag Sup; strength: 500mg & 100000U
Recorded listing: General benefit
Source prices (unrounded): $3.8510; ministry $3.8510
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01926829
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12654
Shortage status: not checked (no credentials)